Tuberculosis, Pulmonary

"Tuberculosis, Pulmonary" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

MYCOBACTERIUM infections of the lung.

Descriptor ID	D014397
MeSH Number(s)	C01.252.410.040.552.846.899 C08.381.922 C08.730.939
Concept/Terms	Tuberculosis, Pulmonary Tuberculosis, Pulmonary Tuberculoses, Pulmonary Pulmonary Tuberculoses Pulmonary Tuberculosis Pulmonary Consumption Consumption, Pulmonary Consumptions, Pulmonary Pulmonary Consumptions Pulmonary Phthisis Phthises, Pulmonary Phthisis, Pulmonary Pulmonary Phthises

Below are MeSH descriptors whose meaning is more general than "Tuberculosis, Pulmonary".

Diseases [C]
Bacterial Infections and Mycoses [C01]
Bacterial Infections [C01.252]
Gram-Positive Bacterial Infections [C01.252.410]
Actinomycetales Infections [C01.252.410.040]
Mycobacterium Infections [C01.252.410.040.552]
Tuberculosis [C01.252.410.040.552.846]
Tuberculosis, Pulmonary [C01.252.410.040.552.846.899]
Respiratory Tract Diseases [C08]
Lung Diseases [C08.381]
Tuberculosis, Pulmonary [C08.381.922]
Respiratory Tract Infections [C08.730]
Tuberculosis, Pulmonary [C08.730.939]

Below are MeSH descriptors whose meaning is related to "Tuberculosis, Pulmonary".

Below are MeSH descriptors whose meaning is more specific than "Tuberculosis, Pulmonary".

Tuberculosis, Pulmonary
Silicotuberculosis

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Tuberculosis, Pulmonary" by people in this website by year, and whether "Tuberculosis, Pulmonary" was a major or minor topic of these publications.

Bar chart showing 98 publications over 25 distinct years, with a maximum of 8 publications in 2016

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1999	0	1	1
2001	1	0	1
2002	0	2	2
2003	0	1	1
2004	2	1	3
2005	4	0	4
2006	4	1	5
2007	5	0	5
2008	2	0	2
2009	3	1	4
2010	2	1	3
2011	2	1	3
2012	5	0	5
2013	2	0	2
2014	6	0	6
2015	3	0	3
2016	8	0	8
2017	5	0	5
2018	5	2	7
2019	7	0	7
2020	5	0	5
2021	6	0	6
2022	2	0	2
2023	4	0	4
2024	3	1	4

Below are the most recent publications written about "Tuberculosis, Pulmonary" by people in Profiles.

Prakash Babu S, Ezhumalai K, Raghupathy K, Karoly M, Chinnakali P, Gupte N, Paradkar M, Devarajan A, Dhanasekaran M, Thiruvengadam K, Dauphinais MR, Gupte AN, Shivakumar SB, Thangakunam B, Christopher DJ, Viswanathan V, Mave V, Gaikwad S, Kinikar A, Kornfeld H, Horsburgh CR, Chandrasekaran P, Hochberg NS, Salgame P, Gupta A, Roy G, Ellner J, Sinha P, Sarkar S. Factors Associated With Unfavorable Treatment Outcomes Among Persons With Pulmonary Tuberculosis: A Multicentric Prospective Cohort Study From India. Clin Infect Dis. 2024 Oct 15; 79(4):1034-1038.

View in: PubMed
Rajamanickam A, Kothandaraman SP, Kumar NP, Viswanathan V, Shanmugam S, Hissar S, Nott S, Kornfeld H, Babu S. Cytokine and chemokine profiles in pulmonary tuberculosis with pre-diabetes. Front Immunol. 2024; 15:1447161.

View in: PubMed
Lai R, Williams T, Rakib T, Lee J, Behar SM. Heterogeneity in lung macrophage control of Mycobacterium tuberculosis is modulated by T cells. Nat Commun. 2024 Jul 08; 15(1):5710.

View in: PubMed
Pandiarajan AN, Kumar NP, Selvaraj N, Ahamed SF, Viswanathan V, Thiruvengadam K, Hissar S, Shanmugam S, Bethunaickan R, Nott S, Kornfeld H, Babu S. Distinct TB-antigen stimulated cytokine profiles as predictive biomarkers for unfavorable treatment outcomes in pulmonary tuberculosis. Front Immunol. 2024; 15:1392256.

View in: PubMed
Viswanathan V, Devarajan A, Kumpatla S, Dhanasekaran M, Babu S, Kornfeld H. Effect of prediabetes on tuberculosis treatment outcomes: A study from South India. Diabetes Metab Syndr. 2023 Jul; 17(7):102801.

View in: PubMed
Queiroz ATL, Vinhaes CL, Fukutani ER, Gupte AN, Kumar NP, Fukutani KF, Arriaga MB, Sterling TR, Babu S, Gaikwad S, Karyakarte R, Mave V, Paradhkar M, Viswanathan V, Gupta A, Andrade BB, Kornfeld H. A multi-center, prospective cohort study of whole blood gene expression in the tuberculosis-diabetes interaction. Sci Rep. 2023 05 12; 13(1):7769.

View in: PubMed
Kumar NP, Nancy A, Viswanathan V, Sivakumar S, Thiruvengadam K, Ahamed SF, Hissar S, Kornfeld H, Babu S. Chitinase and indoleamine 2, 3-dioxygenase are prognostic biomarkers for unfavorable treatment outcomes in pulmonary tuberculosis. Front Immunol. 2023; 14:1093640.

View in: PubMed
Kornfeld H, Procter-Gray E, Kumpatla S, Kane K, Li W, Magee MJ, Babu S, Viswanathan V. Longitudinal trends in glycated hemoglobin during and after tuberculosis treatment. Diabetes Res Clin Pract. 2023 Feb; 196:110242.

View in: PubMed
Thakur P, Sutiwisesak R, Lu YJ, Behar SM. Use of the Human Granulysin Transgenic Mice To Evaluate the Role of Granulysin Expression by CD8 T Cells in Immunity To Mycobacterium tuberculosis. mBio. 2022 12 20; 13(6):e0302022.

View in: PubMed
Kumar NP, Moideen K, Viswanathan V, Sivakumar S, Ahamed SF, Ponnuraja C, Hissar S, Kornfeld H, Babu S. Heightened Microbial Translocation Is a Prognostic Biomarker of Recurrent Tuberculosis. Clin Infect Dis. 2022 11 14; 75(10):1820-1826.

View in: PubMed

People

Explore

Similar Concepts

Top Journals